166 related articles for article (PubMed ID: 32641734)
1. Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2/3 in gastric cancer.
Chen C; Sun X; Xie W; Chen S; Hu Y; Xing D; Xu J; Chen X; Zhao Z; Han Z; Xue X; Shen X; Lin K
Cell Death Dis; 2020 Jul; 11(7):514. PubMed ID: 32641734
[TBL] [Abstract][Full Text] [Related]
2. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer.
Xu JF; Zhao ZG; Ye LL; Zhuge W; Han Z; Zhang TM; Ye SS; Chen WJ; Zhu S; Shi L; Zhang J; Guo AZ; Xue XY; Shen X
Cancer Med; 2017 Sep; 6(9):2063-2075. PubMed ID: 28812328
[TBL] [Abstract][Full Text] [Related]
4. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
Hu Y; Chen C; Tong X; Chen S; Hu X; Pan B; Sun X; Chen Z; Shi X; Hu Y; Shen X; Xue X; Lu M
Cell Death Dis; 2021 Sep; 12(9):842. PubMed ID: 34504059
[TBL] [Abstract][Full Text] [Related]
5. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
6. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
Gareau JR; Reverter D; Lima CD
J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
[TBL] [Abstract][Full Text] [Related]
7. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
[TBL] [Abstract][Full Text] [Related]
9. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
10. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
Flotho A; Werner A
Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
[TBL] [Abstract][Full Text] [Related]
11. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
Werner A; Flotho A; Melchior F
Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
13. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
[TBL] [Abstract][Full Text] [Related]
14. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
[TBL] [Abstract][Full Text] [Related]
15. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
16. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
17. The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.
Sudharsan R; Azuma Y
J Cell Sci; 2012 Dec; 125(Pt 23):5819-29. PubMed ID: 22976298
[TBL] [Abstract][Full Text] [Related]
18. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
19. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
[TBL] [Abstract][Full Text] [Related]
20. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]